Open AccessParasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment
Author(s) -
Georges F. R. Radohery,
Annabelle Walz,
Christin Gumpp,
Mohammed H. CherkaouiRbati,
Nathalie Gobeau,
Jeremy Gower,
Miles P. Davenport,
Matthias Rottmann,
James McCarthy,
Jörg J. Möhrle,
Maria Rebelo,
Claudia DemartaGatsi,
David S. Khoury
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00114-22
Subject(s) - parasitemia , in vivo , drug , plasmodium falciparum , pharmacology , artesunate , biology , malaria , metric (unit) , medicine , immunology , microbiology and biotechnology , operations management , economics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom